Lược sử quá trình hình thành phương pháp triệt đốt rối loạn nhịp tim qua đường ống thông
Tóm tắt
Ở thời kỳ đầu phát triển, thăm dò điện sinh lý học là một thủ thuật xâm lấn được dùng chủ yếu để chẩn đoán xác định và để tìm ra thuốc chống loạn nhịp hiệu quả nhất cho bệnh nhân (1).Báo cáo lâm sàng đầu tiên trên thế giới liên quan đến triệt đốt rối loạn nhịp tim qua đường ống thông thực chất là một “tai nạn nghề nghiệp” trong quá trình thủ thuật thăm dò điện sinh lý học tim. Khi đó, một trong các dây thông điện cực chẩn đoán tình cờ chạm vào điện cực sốc điện trong quá trình sốc điện chuyển nhịp, và kết quả là nút nhĩ thất của bệnh nhân bị triệt đốt (2).
Năm 1982, các nhóm tácgiả Hoa Kỳ do Scheinman và Gallagher đứng đầu đã công bố các chùm ca bệnh triệt đốt nút nhĩ thất sử dụng năng lượng dòng điện một chiều (3, 4). Nhiều nghiên cứu sau đó được tiến hành nhằm cải thiện hiệu quả và nâng cao tính an toàn của thủ thuật. Các thử nghiệm này tập trung vào việc tìm hiểu hiệu quả của các nguồn năng lượng khác nhau trong triệt đốt, bao gồm sử dụng năng lượng lazer và hóa chất. Năm 1987, nhóm các nhà điện sinh lý học tim ở Đại học Munster – CHLB Đức đã báo cáo ca bệnh đầu tiên sử dụng năng lượng sóng có tần số radio (RF) để triệt đốt rối loạn nhịp tim (5). Đây là một bệnh nhân có đường dẫn truyền phụ nằm ở thành bên vòng van ba lá. Kỹ thuật này là một bước đột phá trong triệt đốt rối loạn nhịp vì nó giúp tăng được mức năng lượng đốt tối ưu đồng thời giảm tỷ lệ biến chứng thủng tim. Kết cục là năng lượng sóng có tần số radio đã trở thành nguồn năng lượng thường quy được sử dụng trong triệt đốt rối loạn nhịp tim. Sau đó, nhóm nghiên cứu Đại học Munster tiếp tục là những người đầu tiên đề xuất sử dụng phương thức triệt đốt kiểm soát nhiệt độ -là phương thức giúp nâng cao hơn nữa an toàn thủ thuật và giúp kiểm soát được mức độ tổn thương cơ tim do triệt đốt (6).
Tài liệu tham khảo
1. Wellens HJJ (1971) Electrical stimulation of the heart in the study and treatment of tachycardias. Leiden, Stenfert Kroese.
2. Vedel J, Frank R, Fontaine G et al (1978) Bloc auriculoventriculaire intra-hisien definitif induit au cours d’une exploration endoventriculaire droite. Arch Mal Coer 72:107–112.
3. Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 248:851–855.
4. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closedchest ablation of the atrioventricular conduction system. N Engl J Med 306:194–200.
5. Borggrefe M, Budde T, Podczeck A, Breithardt G (1987) High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol 10:576–582
6. Hindricks G, Haverkamp W, Gulker H, Rissel U, Budde T, Richter KD, Borggrefe M, Breithardt G (1989) Radiofrequency coagulation of ventricular myocardium: improved prediction of lesion size by monitoring catheter tip temperature. Eur Heart J 10:972–984.
7. Kuck KH, Jackman WM, Pitha J, Kunze KP, Carmen L, Schröder S, Nienaber CA (1988) Percutaneous catheter ablation at the mitral annulus in canines using a bipolar epicardial–endocardial electrode configuration. Pacing Clin Electrophysiol 11(6 Pt 1):760–775.
8. Jackman WM, Kuck KH, Naccarelli GV, Carmen L, Pitha J (1988) Radiofrequency current directed across the mitral anulus with a bipolar epicardial–endocardial catheter electrode configuration in dogs. Circulation 78(5 Pt 1):1288–1298.
9. Kuck KH, Schlüter M, Geiger M, Siebels J, Duckeck W (1991) Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 337:1557–1561.
10. Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI et al (1991) Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White syndrome) by radiofrequency current. N Engl J Med 324:1605–1611.
11. Kuck KH, Schlüter M (1991) Single-catheter approach to radiofrequency current ablation of left- sided accessory pathways in patients with Wolff–Parkinson–White syndrome. Circulation 84:2366–2375.
12. Schlüter M, Kuck KH (1992) Catheter ablation from right atrium of anteroseptal accessory pathways using radiofrequency current. J Am Coll Cardiol 19:663–670.
13. Deisenhofer I, Zrenner B, Yin YH, Pitschner HF, Kuniss M, Grossmann G, Stiller S, Luik A, Veltmann C, Frank J, Linner J, Estner HL, Pflaumer A, Wu J, von Bary C, Ucer E, Reents T, Tzeis S, Fichtner S, Kathan S, Karch MR, Jilek C, Ammar S, Kolb C, Liu ZC, Haller B, Schmitt C, Hessling G (2010) Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicentre prospective randomized trial. Circulation 122:2239–2245.
14. Ernst S, Schlüter M, Ouyang F, Khanedani A, Cappato R, Hebe J, Volkmer M, Antz M, Kuck KH (1999) Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 100:2085–2092.
15. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666.
16. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880.
17. Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, Minners J, Neumann FJ, Kalusche D (2007) Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 115:3057–3063.
18. Ouyang F, Bänsch D, Ernst S, Schaumann A, Hachiya H, Chen M, Chun J, Falk P, Khanedani A, Antz M, Kuck KH (2004) Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 110:2090–2096.
19. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, Schaumann A, Chun J, Falk P, Hennig D, Liu X, Bänsch D, Kuck KH (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111:127–135.
20. Kuck KH, Hoffmann BA, Ernst S, Wegscheider K, Treszl A, Metzner A, Eckardt L, Lewalter T, Breithardt G, Willems S (2016) Gap-AF–AFNET 1 Investigators. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-german atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol 9:e003337.
21. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, Neven K, Köktürk B, Konstantinidou M, Metzner A, Fuernkranz A, Kuck KH (2010) Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 122:2368–2377.
22. Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year
outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921–1929.
23. Tilz RR, Heeger CH, Wick A, Saguner AM, Metzner A, Rillig A, Wohlmuth P, Reissmann B, Lemeš C, Maurer T, Santoro F, Riedl J, Sohns C, Mathew S, Kuck KH, Ouyang F (2018) Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 11:e005250
24. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D, CASTLE-AF Investigators (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427
25. Josephson ME. Electrophysiology of ventricular tachycardia: a historical perspective. Pacing Clin Electrophysiol 2003;26:2052 –2067.
26. Wellens HJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 1972;46:216 –226.
27. Guiraudon G, Fontaine G, Frank R, Leandri R, Barra J, Cabrol C. Surgical treatment of ventricular tachycardia guided by ventricular mapping in 23 patients without coronary artery disease. Ann Thorac Surg 1981;32:439 – 450.
28. Josephson ME, Harken AH, Horowitz LN. Long-term results of endocardial resection for sustained ventricular tachycardia in coronary disease patients. Am Heart J 1982;104:51 –57.
29. Moran JM, Kehoe RF, Loeb JM, Sanders JH Jr, Tommaso CL, Michaelis LL. Operative therapy of malignant ventricular rhythm disturbances. Ann Surg 1983;198: 479– 486.
30. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982;306:194
31. Scheinman MM, Morady F, Hess DS, Gonzalez R. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 1982;248:851–855.
32. Fontaine G, Tonet JL, Frank R, Gallais Y, Farenq G, Grosgogeat Y. [Endocavitary fulguration. A new method of treating arrhythmia?]. Ann Cardiol Angeiol (Paris) 1984;33:543–561.
33. Fontaine G, Frank R, Tonet J, Rougier I, Farenq G, Grosgogeat Y. Treatment of rhythm disorders by endocardial fulguration. Am J Cardiol 1989;64:83J–86J.
34. Josephson ME. Clinical cardiac electrophysiology techniques and interpretations. 4th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
35, Willems S, Chen X, Hindricks G, Haverkamp W, Martinez-Rubio A, Hief C, Shenasa M, Breithardt
G. Catheter ablation of ventricular tachycardia using radiofrequency current. Herz 1992;17:171 –178.
36. Blouin LT, Marcus FI, Lampe L. Assessment of effects of a radiofrequency energy field and thermistor location in an electrode catheter on the accuracy of temperature measurement. Pacing Clin Electrophysiol 1991;14(5 Pt 1):807 – 813.
37. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH study Group (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375:31–40.
38. Kuck KH, Tilz RR, Deneke T, Hoffmann BA, Ventura R, Hansen PS, Zarse M, Hohnloser SH, Kautzner J, Willems S; SMS Investigators (2017) Impact of substrate modification by catheter ablation on implantable cardioverter–defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol 10:e004422.
39. Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M (1995) Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy. Circulation 92:1159–1168.
40. Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, Hindricks G, Arya A (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129:728–736.
41. Ouyang F, Cappato R, Ernst S, Goya M, Volkmer M, Hebe J, Antz M, Vogtmann T, Schaumann A, Fotuhi P, Hoffmann-Riem M, Kuck KH (2002) Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation 105:462–469
42. Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M, Burns M, Antz M, Ernst S, Cappato R, Kuck KH (2002) Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 39:500–508.
43. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, Kurzidim K, Berkowitsch A, Koller M, Heintze J, Scholz U, Wetzel U, Schneider MA, Horstkotte D, Hamm CW, Pitschner HF (2008) Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-centre study. J Am Coll Cardiol 52:273–278.
44. Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G (2013) Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol 61:1707–1712.
45. Luik A, Radzewitz A, Kieser M, Walter M, Bramlage P, Hörmann P, Schmidt K, Horn N, Brinkmeier- Theofanopoulou M, Kunzmann K, Riexinger T, Schymik G, Merkel M, Schmitt C (2015) Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study. Circulation 132:1311–1319.
46. Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C, FIRE AND ICE Investigators (2016) Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 374:2235–2245.
47. Chun KR, Stich M, Fürnkranz A, Bordignon S, Perrotta L, Dugo D, Bologna F, Schmidt B (2017) Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial. Heart Rhythm 14:495–500.
48. Wissner E, Heeger CH, Grahn H, Reissmann B, Wohlmuth P, Lemes C, Rausch P, Mathew S, Rillig A, Deiss S, Maurer T, Lin T, Tilz RR, Ouyang F, Kuck KH, Metzner A (2015) Oneyear clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation. Europace 17:1236–1240.
49. Reissmann B, Wissner E, Deiss S, Heeger C, Schlueter M, Wohlmuth P, Lemes C, Mathew S, Maurer T, Sohns C, Saguner A, Santoro F, Hayashi K, Riedl J, Ouyang F, Kuck KH, Metzner A (2017) First insights into cryoballoon-based pulmonary vein isolation taking the individual time-to-isolation into account. Europace 19:1676–1680.
50. Schmidt B, Neuzil P, Luik A, Osca Asensi J, Schrickel JW, Deneke T, Bordignon S, Petru J, Merkel M, Sediva L, Klostermann A, Perrotta L, Cano O, Chun KRJ (2017) Laser balloon or wide-area circumferential irrigated radiofrequency ablation for persistent atrial fibrillation: a multicentre prospective randomized study. Circ Arrhythm Electrophysiol 10:e005767.
51. Kuck KH, Reddy VY, Schmidt B, Natale A, Neuzil P, Saoudi N, Kautzner J, Herrera C, Hindricks G, Jaïs P, Nakagawa H, Lambert H, Shah DC (2012) A novel radiofrequency ablation catheter using contact force sensing: TOCCATA study. Heart Rhythm 9:18–23.
52. Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH (2013) Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 6:327–333.
53. Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH (2015) EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 17:1229–1235.
54. Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jaïs P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH (2012) The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9:1789–1795.
55. Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J, Hachiya H, Bänsch D, Antz M, Kuck KH (2004) Initial experience with remote catheter ablation using a novel magnetic navigation system: magnetic remote catheter ablation. Circulation 109:1472–1475.
56. Chun JK, Ernst S, Matthews S, Schmidt B, Bansch D, Boczor S, Ujeyl A, Antz M, Ouyang F, Kuck KH (2007) Remote-controlled catheter ablation of accessory pathways: results from the magnetic laboratory. Eur Heart J 28:190–195.
57. Arya A, Kottkamp H, Piorkowski C, Bollmann A, Gerdes-Li JH, Riahi S, Esato M, Hindricks G (2008) Initial clinical experience with a remote magnetic catheter navigation system for ablation of cavotricuspid isthmus-dependent right atrial flutter. Pacing Clin Electrophysiol 31:597–603.
58. Rillig A, Schmidt B, Di Biase L, Lin T, Scholz L, Heeger CH, Metzner A, Steven D, Wohlmuth P, Willems S, Trivedi C, Galllinghouse JG, Natale A, Ouyang F, Kuck KH, Tilz RR (2017) Manual versus robotic catheter ablation for the treatment of atrial fibrillation: the Man and Machine trial. JACC Clin Electrophysiol 3:875–883.
59. Sommer P, Grothoff M, Eitel C, Gaspar T, Piorkowski C, Gutberlet M, Hindricks G (2013) Feasibility of real-time magnetic resonance imaging-guided electrophysiology studies in humans. Europace 15:101–108.
60. Piorkowski C, Grothoff M, Gaspar T, Eitel C, Sommer P, Huo Y, John S, Gutberlet M, Hindricks G (2013) Cavotricuspid isthmus ablation guided by real-time magnetic resonance imaging. Circ Arrhythm Electrophysiol 6:e7–e10.